LORATADINE

LORATADINE was reported 108750 times

LORATADINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 FAILURE OF CHILD RESISTANT MECHANISM FOR PHARMACEUTICAL PRODUCT 86 0.1963
1 HUMAN RHINOVIRUS TEST POSITIVE 68 0.1823
2 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 928 0.1364
3 RESPIRATORY SYNCYTIAL VIRUS TEST POSITIVE 72 0.1024
4 CHRONIC SPONTANEOUS URTICARIA 100 0.0862
5 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 80 0.0753
6 MAST CELL ACTIVATION SYNDROME 91 0.0648
7 NEPHROGENIC ANAEMIA 287 0.0619
8 HYPERPARATHYROIDISM SECONDARY 146 0.0582
9 REBOUND ACID HYPERSECRETION 152 0.0502
10 ESSENTIAL HYPERTENSION 87 0.0475
11 INFUSION SITE DISCHARGE 77 0.0439
12 EXTRA DOSE ADMINISTERED 1666 0.0411
13 PRODUCT PACKAGE ASSOCIATED INJURY 85 0.0381
14 DRUG EFFECT DELAYED 172 0.0379
15 PRE-EXISTING CONDITION IMPROVED 235 0.0376
16 EXPIRED PRODUCT ADMINISTERED 1203 0.0362
17 RHINITIS ALLERGIC 160 0.0359
18 SEASONAL ALLERGY 506 0.0357
19 PATIENT DISSATISFACTION WITH TREATMENT 68 0.0353
20 INFUSION SITE INFECTION 78 0.0335
21 INFUSION SITE HAEMORRHAGE 107 0.0325
22 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 175 0.0321
23 INFUSION SITE PRURITUS 101 0.0320
24 TONGUE BITING 65 0.0315
25 MULTIPLE ALLERGIES 222 0.0283
26 INFUSION SITE SWELLING 175 0.0278
27 CHRONIC SINUSITIS 103 0.0274
28 END STAGE RENAL DISEASE 498 0.0273
29 CHOLECYSTITIS CHRONIC 176 0.0263
30 NASAL DRYNESS 160 0.0255
31 DEVICE INFUSION ISSUE 63 0.0254
32 INFUSION SITE ERYTHEMA 213 0.0252
33 UPPER-AIRWAY COUGH SYNDROME 205 0.0249
34 INFUSION SITE PAIN 320 0.0248
35 PARANASAL SINUS DISCOMFORT 89 0.0235
36 SNEEZING 517 0.0230
37 EAR CONGESTION 61 0.0225
38 SPINAL OSTEOARTHRITIS 193 0.0219
39 SNORING 83 0.0219
40 CHRONIC KIDNEY DISEASE 1661 0.0218
41 DIABETIC NEUROPATHY 107 0.0216
42 EXPIRED DRUG ADMINISTERED 106 0.0214
43 DRUG EFFECT INCOMPLETE 771 0.0212
44 SINUS HEADACHE 122 0.0205
45 RHINOVIRUS INFECTION 77 0.0198
46 ANXIETY DISORDER 66 0.0197
47 SLEEP APNOEA SYNDROME 372 0.0195
48 OTITIS MEDIA 64 0.0194
49 THERAPEUTIC RESPONSE UNEXPECTED 861 0.0192
50 PRODUCT ADMINISTRATION INTERRUPTED 149 0.0190
51 NON-CARDIAC CHEST PAIN 59 0.0186
52 SINUS CONGESTION 250 0.0185
53 POST-TRAUMATIC STRESS DISORDER 124 0.0185
54 SINUS DISORDER 365 0.0184
55 VITAMIN D DEFICIENCY 178 0.0182
56 PNEUMONIA ASPIRATION 452 0.0181
57 HYPERLIPIDAEMIA 212 0.0177
58 INCORRECT DOSAGE ADMINISTERED 85 0.0174
59 MONOCYTE COUNT INCREASED 63 0.0173
60 INTERVERTEBRAL DISC DEGENERATION 160 0.0173
61 NASAL CONGESTION 1016 0.0173
62 ASTHMATIC CRISIS 63 0.0172
63 MOUTH HAEMORRHAGE 125 0.0170
64 VITAMIN B12 DEFICIENCY 69 0.0170
65 DRY THROAT 173 0.0170
66 DERMATITIS CONTACT 194 0.0170
67 PARANASAL SINUS HYPERSECRETION 64 0.0168
68 ACCIDENTAL OVERDOSE 613 0.0167
69 RHINORRHOEA 1080 0.0167
70 LACRIMATION INCREASED 504 0.0167
71 PHARYNGEAL SWELLING 163 0.0166
72 NASAL DISCOMFORT 132 0.0166
73 GASTROOESOPHAGEAL REFLUX DISEASE 1338 0.0166
74 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 118 0.0165
75 HYPERURICAEMIA 66 0.0160
76 RENAL CYST 127 0.0160
77 IMPAIRED QUALITY OF LIFE 228 0.0158
78 SINUSITIS 1625 0.0158
79 SOMNAMBULISM 104 0.0158
80 HIATUS HERNIA 204 0.0157
81 PRODUCT TASTE ABNORMAL 210 0.0155
82 EAR DISCOMFORT 158 0.0154
83 THROAT IRRITATION 676 0.0151
84 ECONOMIC PROBLEM 228 0.0150
85 TEMPERATURE INTOLERANCE 155 0.0150
86 ARTHROPOD BITE 111 0.0150
87 UPPER RESPIRATORY TRACT INFECTION 691 0.0149
88 SOMNOLENCE 2987 0.0148
89 OSTEOPENIA 223 0.0147
90 HAEMOGLOBIN INCREASED 67 0.0147
91 HAIR DISORDER 121 0.0147
92 FOOD ALLERGY 113 0.0146
93 ENURESIS 59 0.0146
94 FEELING DRUNK 108 0.0145
95 OROPHARYNGEAL DISCOMFORT 131 0.0145
96 EAR PAIN 281 0.0144
97 PERIORBITAL OEDEMA 75 0.0144
98 TENSION HEADACHE 62 0.0144
99 SPUTUM DISCOLOURED 136 0.0143
100 HEAD DISCOMFORT 252 0.0142
101 INCREASED UPPER AIRWAY SECRETION 73 0.0142
102 POOR QUALITY SLEEP 304 0.0141
103 LIP SWELLING 470 0.0141
104 RENAL INJURY 417 0.0140
105 RALES 81 0.0139
106 SKIN WARM 81 0.0139
107 MOUTH SWELLING 80 0.0139
108 RESPIRATORY TRACT CONGESTION 220 0.0138
109 BRONCHITIS 1021 0.0138
110 ASTHMA 1558 0.0138
111 DYSLIPIDAEMIA 70 0.0138
112 OVERWEIGHT 74 0.0138
113 RHINITIS 111 0.0138
114 SCOLIOSIS 85 0.0137
115 MIDDLE INSOMNIA 252 0.0135
116 DIVERTICULUM INTESTINAL 59 0.0135
117 TRICUSPID VALVE INCOMPETENCE 107 0.0135
118 OBSESSIVE-COMPULSIVE DISORDER 108 0.0134
119 ATELECTASIS 130 0.0134
120 EAR INFECTION 357 0.0134
121 DRUG EFFECT DECREASED 722 0.0134
122 SCRATCH 141 0.0134
123 HAIR COLOUR CHANGES 165 0.0132
124 CHOLECYSTITIS ACUTE 75 0.0132
125 URTICARIA 2209 0.0132
126 MENISCUS INJURY 81 0.0132
127 INITIAL INSOMNIA 135 0.0131
128 HYPERVOLAEMIA 65 0.0131
129 CARPAL TUNNEL SYNDROME 183 0.0131
130 LIGAMENT SPRAIN 129 0.0130
131 BODY HEIGHT DECREASED 138 0.0129
132 BLOOD MAGNESIUM DECREASED 111 0.0128
133 TENDERNESS 134 0.0128
134 FEELING JITTERY 245 0.0128
135 MAJOR DEPRESSION 93 0.0127
136 ENERGY INCREASED 75 0.0127
137 ANHEDONIA 333 0.0127
138 EYE PRURITUS 424 0.0126
139 HAIR TEXTURE ABNORMAL 168 0.0125
140 RESTLESS LEGS SYNDROME 228 0.0125
141 PSYCHOMOTOR HYPERACTIVITY 208 0.0125
142 DIVERTICULUM 89 0.0125
143 THROAT TIGHTNESS 338 0.0125
144 WHEEZING 739 0.0124
145 NASAL POLYPS 61 0.0124
146 DIZZINESS POSTURAL 120 0.0124
147 POOR QUALITY DRUG ADMINISTERED 80 0.0123
148 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 677 0.0123
149 GALLBLADDER DISORDER 220 0.0123
150 SWELLING FACE 800 0.0123
151 PARAESTHESIA ORAL 177 0.0123
152 PRODUCTIVE COUGH 585 0.0122
153 SWOLLEN TONGUE 375 0.0120
154 EYE SWELLING 442 0.0119
155 NOCTURIA 143 0.0118
156 FACIAL PAIN 105 0.0118
157 PHOTOSENSITIVITY REACTION 194 0.0117
158 CYSTIC FIBROSIS 65 0.0117
159 BLOOD POTASSIUM DECREASED 353 0.0117
160 ODYNOPHAGIA 70 0.0117
161 EXOSTOSIS 107 0.0117
162 ROTATOR CUFF SYNDROME 149 0.0116
163 IMPAIRED GASTRIC EMPTYING 158 0.0116
164 GASTROENTERITIS VIRAL 209 0.0116
165 ORAL PAIN 258 0.0115
166 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 336 0.0115
167 EXERCISE TOLERANCE DECREASED 66 0.0115
168 NEPHROPATHY 107 0.0114
169 MADAROSIS 133 0.0114
170 MUSCULOSKELETAL DISCOMFORT 197 0.0114
171 DRY MOUTH 928 0.0114
172 SECRETION DISCHARGE 143 0.0114
173 OROPHARYNGEAL PAIN 1056 0.0114
174 MITRAL VALVE INCOMPETENCE 129 0.0114
175 FRUSTRATION TOLERANCE DECREASED 92 0.0114
176 IRON DEFICIENCY ANAEMIA 105 0.0114
177 ANKLE FRACTURE 176 0.0114
178 PSYCHOLOGICAL TRAUMA 98 0.0113
179 VITAMIN D DECREASED 97 0.0113
180 COUGH 3178 0.0113
181 MUSCLE TIGHTNESS 183 0.0113
182 OSTEOARTHRITIS 477 0.0112
183 WALKING AID USER 74 0.0112
184 MUSCLE STRAIN 97 0.0112
185 ANGIOEDEMA 495 0.0112
186 PRODUCT USE ISSUE 2102 0.0112
187 ANAPHYLACTIC REACTION 617 0.0112
188 SWELLING OF EYELID 70 0.0111
189 THERMAL BURN 79 0.0111
190 WEIGHT FLUCTUATION 116 0.0111
191 INFUSION SITE EXTRAVASATION 69 0.0111
192 PAPULE 78 0.0111
193 OBESITY 176 0.0110
194 RED BLOOD CELL COUNT DECREASED 314 0.0110
195 HEART RATE INCREASED 1087 0.0110
196 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 186 0.0109
197 BIPOLAR DISORDER 119 0.0109
198 BRUXISM 59 0.0109
199 ORAL CANDIDIASIS 144 0.0109
200 CHEST DISCOMFORT 1117 0.0109
201 EPISTAXIS 815 0.0109
202 INTERVERTEBRAL DISC PROTRUSION 238 0.0109
203 ORAL DISCOMFORT 151 0.0109
204 DYSPNOEA EXERTIONAL 409 0.0108
205 CONCUSSION 84 0.0108
206 BONE PAIN 633 0.0108
207 STREPTOCOCCAL INFECTION 60 0.0108
208 BRAIN FOG 169 0.0108
209 PAIN IN JAW 305 0.0108
210 PHARYNGEAL OEDEMA 165 0.0107
211 CHOLELITHIASIS 351 0.0107
212 GLUCOSE TOLERANCE IMPAIRED 63 0.0106
213 PHARYNGITIS STREPTOCOCCAL 115 0.0106
214 ONYCHOCLASIS 73 0.0106
215 THIRST 189 0.0106
216 PHARYNGITIS 131 0.0106
217 PALPITATIONS 1236 0.0105
218 INCREASED TENDENCY TO BRUISE 97 0.0105
219 SCREAMING 67 0.0105
220 CARDIAC MURMUR 91 0.0105
221 SPINAL DISORDER 99 0.0104
222 TOOTHACHE 189 0.0104
223 DECUBITUS ULCER 85 0.0104
224 HYPERSENSITIVITY 1933 0.0104
225 OSTEOPOROSIS 428 0.0104
226 INSURANCE ISSUE 159 0.0104
227 RENAL FAILURE 1376 0.0104
228 HAEMORRHOIDS 202 0.0103
229 OBSTRUCTIVE AIRWAYS DISORDER 115 0.0103
230 HYPERSOMNIA 296 0.0103
231 CARDIOMEGALY 127 0.0103
232 PHOTOPHOBIA 194 0.0103
233 HEPATIC STEATOSIS 192 0.0103
234 VENTRICULAR EXTRASYSTOLES 107 0.0103
235 HYPOAESTHESIA ORAL 155 0.0103
236 MICTURITION URGENCY 117 0.0102
237 FLANK PAIN 96 0.0102
238 ACUTE RESPIRATORY FAILURE 197 0.0102
239 RASH PRURITIC 555 0.0102
240 MUSCULOSKELETAL CHEST PAIN 158 0.0102
241 EYE DISCHARGE 106 0.0102
242 FULL BLOOD COUNT DECREASED 205 0.0102
243 BURSITIS 123 0.0101
244 HEART RATE IRREGULAR 229 0.0101
245 BLOOD ALBUMIN DECREASED 80 0.0101
246 SKIN PLAQUE 85 0.0101
247 NEURALGIA 245 0.0101
248 CHOLECYSTITIS 120 0.0101
249 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 524 0.0100
250 DRY EYE 501 0.0100
251 DENTAL CARIES 111 0.0100
252 SUPRAVENTRICULAR TACHYCARDIA 96 0.0100
253 LEFT VENTRICULAR DYSFUNCTION 67 0.0100
254 GASTRITIS 263 0.0100
255 DRUG INEFFECTIVE 13170 0.0100
256 NERVE COMPRESSION 92 0.0100
257 BLOOD IRON DECREASED 118 0.0099
258 TOOTH INFECTION 131 0.0099
259 BOWEL MOVEMENT IRREGULARITY 76 0.0099
260 INSOMNIA 2641 0.0099
261 SCIATICA 158 0.0099
262 CELLULITIS 499 0.0099
263 NERVOUSNESS 517 0.0099
264 SKIN INFECTION 111 0.0099
265 BLOOD PRESSURE INCREASED 1512 0.0099
266 HAEMATOCRIT DECREASED 196 0.0099
267 RENAL FAILURE CHRONIC 76 0.0099
268 TUBULOINTERSTITIAL NEPHRITIS 185 0.0099
269 PRURITUS GENERALISED 213 0.0098
270 LIMB INJURY 267 0.0098
271 FOOT FRACTURE 186 0.0098
272 SLUGGISHNESS 100 0.0098
273 VITREOUS FLOATERS 96 0.0098
274 RESPIRATORY TRACT INFECTION 254 0.0097
275 WHITE BLOOD CELL COUNT ABNORMAL 62 0.0097
276 DYSPHONIA 567 0.0097
277 BREAST MASS 65 0.0097
278 RETCHING 206 0.0097
279 ARTERIOSCLEROSIS CORONARY ARTERY 64 0.0097
280 IRRITABLE BOWEL SYNDROME 207 0.0096
281 OXYGEN SATURATION DECREASED 542 0.0096
282 HAND FRACTURE 68 0.0096
283 NECK PAIN 536 0.0096
284 PRODUCT PACKAGING ISSUE 91 0.0096
285 CRYING 348 0.0096
286 ANXIETY 2724 0.0096
287 FEELING COLD 266 0.0095
288 MIGRAINE 912 0.0095
289 PULMONARY MASS 142 0.0095
290 GOUT 171 0.0095
291 DRUG EFFECT LESS THAN EXPECTED 141 0.0095
292 PRODUCT PRESCRIBING ISSUE 207 0.0095
293 TENDONITIS 147 0.0095
294 SENSITIVE SKIN 70 0.0095
295 FEELING HOT 581 0.0095
296 RASH MACULAR 331 0.0095
297 PANIC ATTACK 345 0.0095
298 VIRAL INFECTION 315 0.0095
299 TINNITUS 434 0.0094
300 CHEST PAIN 1744 0.0094
301 HOSPICE CARE 93 0.0094
302 LYMPHOEDEMA 65 0.0094
303 RENAL TUBULAR NECROSIS 92 0.0094
304 FIBROMYALGIA 228 0.0094
305 BLOOD UREA INCREASED 157 0.0094
306 LIMB DISCOMFORT 290 0.0094
307 URINARY TRACT INFECTION 1593 0.0093
308 LOWER GASTROINTESTINAL HAEMORRHAGE 69 0.0093
309 CONJUNCTIVITIS 173 0.0093
310 SENSORY LOSS 75 0.0093
311 DEPRESSION 2117 0.0093
312 UTERINE LEIOMYOMA 68 0.0093
313 TYPE 2 DIABETES MELLITUS 313 0.0093
314 LETHARGY 534 0.0093
315 FLUSHING 942 0.0093
316 SMALL INTESTINAL OBSTRUCTION 114 0.0093
317 SENSATION OF FOREIGN BODY 78 0.0092
318 HOT FLUSH 697 0.0092
319 QUALITY OF LIFE DECREASED 124 0.0092
320 NEUROPATHY PERIPHERAL 879 0.0092
321 DYSPEPSIA 909 0.0092
322 DIVERTICULITIS 256 0.0092
323 BLOOD CHOLESTEROL INCREASED 429 0.0092
324 NEUTROPHIL COUNT INCREASED 94 0.0092
325 ELECTROCARDIOGRAM ABNORMAL 72 0.0092
326 SCAR 157 0.0092
327 PULMONARY HYPERTENSION 191 0.0092
328 POLYP 60 0.0092
329 DYSURIA 337 0.0091
330 RENAL PAIN 97 0.0091
331 TONGUE DISORDER 66 0.0091
332 HYPOXIA 321 0.0091
333 BLOOD ALKALINE PHOSPHATASE INCREASED 226 0.0091
334 INFUSION RELATED REACTION 603 0.0091
335 COMA 433 0.0091
336 DECREASED ACTIVITY 98 0.0091
337 NIGHT SWEATS 292 0.0091
338 BACK DISORDER 147 0.0090
339 PRURITUS 3469 0.0090
340 SLEEP DISORDER 636 0.0090
341 RESPIRATORY RATE INCREASED 80 0.0090
342 HYSTERECTOMY 78 0.0090
343 ANAL INCONTINENCE 81 0.0090
344 JOINT EFFUSION 62 0.0090
345 SKIN SWELLING 78 0.0090
346 BACK PAIN 2083 0.0090
347 BLADDER DISORDER 89 0.0090
348 DISTURBANCE IN ATTENTION 483 0.0089
349 FEELING ABNORMAL 2144 0.0089
350 LYMPHOCYTE COUNT DECREASED 158 0.0089
351 CHOLECYSTECTOMY 102 0.0089
352 ACUTE KIDNEY INJURY 1366 0.0089
353 SKIN LACERATION 97 0.0089
354 DIZZINESS 4447 0.0089
355 ANOSMIA 129 0.0089
356 COORDINATION ABNORMAL 124 0.0089
357 POSTOPERATIVE WOUND INFECTION 60 0.0089
358 CONSTIPATION 1935 0.0089
359 DYSGEUSIA 659 0.0089
360 RESPIRATORY SYNCYTIAL VIRUS INFECTION 77 0.0088
361 TOOTH ABSCESS 90 0.0088
362 BRONCHOSPASM 126 0.0088
363 HYPOTHYROIDISM 281 0.0088
364 PULMONARY CONGESTION 116 0.0088
365 ARTHRITIS 690 0.0088
366 WRIST FRACTURE 105 0.0088
367 CHILLS 1025 0.0087
368 MASS 122 0.0087
369 HEADACHE 5465 0.0087
370 MENTAL STATUS CHANGES 242 0.0087
371 CHOKING 170 0.0087
372 FATIGUE 6784 0.0087
373 SPLENOMEGALY 102 0.0087
374 POLLAKIURIA 363 0.0087
375 EYE PAIN 491 0.0087
376 DYSPNOEA 4917 0.0087
377 HAEMOPTYSIS 242 0.0087
378 APHONIA 121 0.0087
379 MUSCLE SPASMS 1589 0.0087
380 ABDOMINAL DISCOMFORT 1451 0.0086
381 AFFECTIVE DISORDER 68 0.0086
382 SKIN HAEMORRHAGE 128 0.0086
383 BLOOD POTASSIUM INCREASED 140 0.0086
384 CORONARY ARTERY DISEASE 261 0.0086
385 RIB FRACTURE 177 0.0086
386 INFLUENZA 959 0.0086
387 EXTRASYSTOLES 60 0.0086
388 GASTROINTESTINAL INFECTION 77 0.0086
389 BLOOD URINE PRESENT 163 0.0086
390 PNEUMONIA 2772 0.0086
391 HUNGER 119 0.0085
392 TORSADE DE POINTES 67 0.0085
393 FLATULENCE 483 0.0085
394 PERIPHERAL SWELLING 1311 0.0085
395 FULL BLOOD COUNT ABNORMAL 90 0.0085
396 THERAPEUTIC RESPONSE SHORTENED 282 0.0085
397 MALNUTRITION 95 0.0085
398 NASOPHARYNGITIS 1565 0.0085
399 RASH PAPULAR 190 0.0085
400 CYSTITIS 269 0.0084
401 BODY TEMPERATURE DECREASED 83 0.0084
402 EMPHYSEMA 85 0.0084
403 JOINT RANGE OF MOTION DECREASED 113 0.0084
404 RIGHT VENTRICULAR FAILURE 59 0.0084
405 SCAB 96 0.0084
406 EYE INFECTION 95 0.0084
407 FOOT DEFORMITY 93 0.0084
408 ABDOMINAL PAIN UPPER 1726 0.0084
409 FEBRILE NEUTROPENIA 556 0.0084
410 ECZEMA 438 0.0084
411 BLOOD CALCIUM DECREASED 94 0.0084
412 DRUG SCREEN POSITIVE 66 0.0083
413 BLOOD PRESSURE ABNORMAL 166 0.0083
414 SPINAL COMPRESSION FRACTURE 69 0.0083
415 DERMATITIS ATOPIC 440 0.0083
416 FLUID RETENTION 424 0.0083
417 ABNORMAL DREAMS 230 0.0083
418 BLOOD SODIUM DECREASED 157 0.0083
419 BLOOD PRESSURE SYSTOLIC INCREASED 162 0.0083
420 LACERATION 78 0.0083
421 EOSINOPHIL COUNT INCREASED 69 0.0083
422 BALANCE DISORDER 714 0.0083
423 DYSSTASIA 241 0.0082
424 PURPURA 73 0.0082
425 SKIN LESION 226 0.0082
426 SKIN FISSURES 161 0.0082
427 DISCOMFORT 502 0.0082
428 PRESYNCOPE 200 0.0082
429 ILLNESS 845 0.0082
430 CHROMATURIA 185 0.0082
431 PARAESTHESIA 1288 0.0082
432 UPPER LIMB FRACTURE 163 0.0082
433 SUNBURN 61 0.0082
434 NEPHROLITHIASIS 375 0.0082
435 DEEP VEIN THROMBOSIS 531 0.0082
436 MUSCULOSKELETAL PAIN 428 0.0082
437 MOOD ALTERED 222 0.0081
438 PRODUCT USE COMPLAINT 128 0.0081
439 CANDIDA INFECTION 137 0.0081
440 URINARY INCONTINENCE 240 0.0081
441 RASH 3525 0.0081
442 HYPERCHOLESTEROLAEMIA 78 0.0081
443 UNEVALUABLE EVENT 611 0.0081
444 ANGER 273 0.0081
445 OEDEMA PERIPHERAL 984 0.0081
446 BONE DISORDER 147 0.0081
447 CYST 100 0.0080
448 ORAL DISORDER 59 0.0080
449 ULCER 128 0.0080
450 GINGIVAL PAIN 64 0.0080
451 ASPIRATION 88 0.0080
452 CONTUSION 773 0.0080
453 WHITE BLOOD CELL COUNT INCREASED 308 0.0080
454 DEHYDRATION 1070 0.0080
455 SALIVARY HYPERSECRETION 80 0.0080
456 PSYCHIATRIC SYMPTOM 59 0.0080
457 RASH ERYTHEMATOUS 382 0.0080
458 OCULAR HYPERAEMIA 379 0.0080
459 COVID-19 1401 0.0080
460 DEPRESSED MOOD 422 0.0080
461 TOOTH DISORDER 177 0.0080
462 PNEUMONIA BACTERIAL 73 0.0079
463 FACE OEDEMA 134 0.0079
464 BURNING SENSATION 557 0.0079
465 BODY TEMPERATURE INCREASED 162 0.0079
466 BLOOD COUNT ABNORMAL 120 0.0079
467 TOOTH FRACTURE 87 0.0079
468 PARANOIA 136 0.0079
469 CYTOKINE RELEASE SYNDROME 158 0.0079
470 PAIN IN EXTREMITY 2317 0.0079
471 VISION BLURRED 1079 0.0079
472 LYMPHADENOPATHY 278 0.0078
473 PRODUCT USE IN UNAPPROVED INDICATION 1945 0.0078
474 FLUID OVERLOAD 114 0.0078
475 HYPOMAGNESAEMIA 109 0.0078
476 PAROSMIA 59 0.0078
477 HYPOAESTHESIA 1170 0.0078
478 IMMUNE SYSTEM DISORDER 103 0.0078
479 WHITE BLOOD CELL COUNT DECREASED 847 0.0078
480 ATRIAL FIBRILLATION 760 0.0078
481 NIGHTMARE 270 0.0078
482 SKIN DISORDER 260 0.0078
483 VERTIGO 475 0.0078
484 HYPERTENSION 1649 0.0078
485 HYPOKALAEMIA 358 0.0077
486 OCULAR DISCOMFORT 87 0.0077
487 GASTROENTERITIS 113 0.0077
488 EYELID OEDEMA 90 0.0077
489 WRONG DRUG ADMINISTERED 69 0.0077
490 TRANSIENT ISCHAEMIC ATTACK 261 0.0077
491 DERMATITIS 162 0.0077
492 PULMONARY ARTERIAL HYPERTENSION 112 0.0077
493 MENSTRUAL DISORDER 64 0.0077
494 ACTIVITIES OF DAILY LIVING IMPAIRED 153 0.0077
495 EUPHORIC MOOD 79 0.0077
496 FUNGAL INFECTION 257 0.0077
497 PRODUCT DOSE OMISSION IN ERROR 218 0.0077
498 UROSEPSIS 71 0.0077
499 MOOD SWINGS 245 0.0077
500 ORAL HERPES 150 0.0077
501 MUSCLE DISORDER 62 0.0076
502 CLOSTRIDIUM DIFFICILE INFECTION 167 0.0076
503 HEAD INJURY 242 0.0076
504 PERIPHERAL COLDNESS 105 0.0076
505 ATRIAL FLUTTER 61 0.0076
506 DIARRHOEA 4927 0.0076
507 BACK INJURY 83 0.0076
508 ABNORMAL BEHAVIOUR 302 0.0076
509 BLOOD TEST ABNORMAL 107 0.0076
510 GRIP STRENGTH DECREASED 67 0.0076
511 PLATELET COUNT INCREASED 99 0.0076
512 HYPERHIDROSIS 978 0.0076
513 CORONARY ARTERY OCCLUSION 104 0.0076
514 IMMUNODEFICIENCY 113 0.0076
515 ABDOMINAL DISTENSION 791 0.0076
516 SKIN DISCOLOURATION 348 0.0076
517 STOMATITIS 459 0.0076
518 NAUSEA 5983 0.0076
519 BACTERIAL INFECTION 141 0.0076
520 SYNCOPE 756 0.0075
521 JOINT STIFFNESS 198 0.0075
522 DYSARTHRIA 284 0.0075
523 PULMONARY THROMBOSIS 82 0.0075
524 ERYTHEMA 1543 0.0075
525 OESOPHAGITIS 82 0.0075
526 BREAST PAIN 80 0.0075
527 POST PROCEDURAL INFECTION 61 0.0075
528 DYSPHAGIA 712 0.0075
529 KIDNEY INFECTION 147 0.0075
530 JOINT INJURY 160 0.0075
531 COLD SWEAT 132 0.0075
532 BLOOD TRIGLYCERIDES INCREASED 132 0.0075
533 INFLAMMATORY BOWEL DISEASE 73 0.0075
534 MYALGIA 1268 0.0075
535 PLATELET COUNT DECREASED 794 0.0074
536 CATARACT 443 0.0074
537 HICCUPS 61 0.0074
538 PERSONALITY CHANGE 69 0.0074
539 EMOTIONAL DISORDER 229 0.0074
540 SWELLING 695 0.0074
541 IRRITABILITY 446 0.0074
542 DEVICE RELATED INFECTION 114 0.0074
543 RENAL DISORDER 345 0.0074
544 ASTHENIA 2780 0.0074
545 RESPIRATORY DISORDER 221 0.0074
546 VENTRICULAR FIBRILLATION 82 0.0074
547 AGEUSIA 184 0.0074
548 WEIGHT INCREASED 1646 0.0073
549 OEDEMA 398 0.0073
550 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 522 0.0073
551 WEIGHT DECREASED 2048 0.0073
552 INJURY 515 0.0073
553 EATING DISORDER 156 0.0073
554 TASTE DISORDER 148 0.0073
555 MUSCLE TWITCHING 168 0.0073
556 PETECHIAE 76 0.0073
557 PNEUMONITIS 198 0.0073
558 LIP DRY 66 0.0073
559 THINKING ABNORMAL 135 0.0072
560 CARDIOMYOPATHY 107 0.0072
561 GLOSSODYNIA 162 0.0072
562 AGITATION 531 0.0072
563 ARTERIOSCLEROSIS 68 0.0072
564 GLAUCOMA 139 0.0072
565 TREMOR 1197 0.0072
566 OVARIAN CYST 72 0.0072
567 GASTRIC DISORDER 247 0.0072
568 EYE HAEMORRHAGE 96 0.0072
569 FALL 2385 0.0072
570 DERMATITIS ALLERGIC 90 0.0071
571 PRODUCT PHYSICAL ISSUE 144 0.0071
572 LUNG INFILTRATION 63 0.0071
573 BLOOD PRESSURE FLUCTUATION 171 0.0071
574 SUICIDAL IDEATION 652 0.0071
575 ARTHRALGIA 2960 0.0071
576 LOCALISED INFECTION 172 0.0071
577 GASTRIC ULCER 135 0.0071
578 EYE IRRITATION 408 0.0071
579 FEAR 190 0.0071
580 BLISTER 396 0.0070
581 SINUS TACHYCARDIA 100 0.0070
582 STAPHYLOCOCCAL INFECTION 232 0.0070
583 NERVE INJURY 78 0.0070
584 BLOOD PRESSURE DECREASED 466 0.0070
585 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 62 0.0070
586 GENERALISED TONIC-CLONIC SEIZURE 116 0.0070
587 AMNESIA 456 0.0070
588 INCONTINENCE 74 0.0070
589 PSEUDOMONAS INFECTION 60 0.0070
590 EYE DISORDER 230 0.0070
591 LOCAL SWELLING 122 0.0070
592 RASH GENERALISED 181 0.0070
593 OSTEOMYELITIS 126 0.0070
594 URINARY RETENTION 232 0.0069
595 THYROID DISORDER 107 0.0069
596 PULMONARY EMBOLISM 659 0.0069
597 MOUTH ULCERATION 146 0.0069
598 CARDIAC FAILURE CONGESTIVE 556 0.0069
599 PYREXIA 2392 0.0069
600 DECREASED APPETITE 1603 0.0069
601 PELVIC PAIN 125 0.0069
602 TRANSFUSION 72 0.0069
603 RED BLOOD CELL SEDIMENTATION RATE INCREASED 76 0.0069
604 FEEDING DISORDER 139 0.0068
605 HYPOPHAGIA 175 0.0068
606 ADRENAL INSUFFICIENCY 83 0.0068
607 GROIN PAIN 60 0.0068
608 BONE DENSITY DECREASED 214 0.0068
609 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 485 0.0068
610 SARS-COV-2 TEST POSITIVE 90 0.0068
611 NO THERAPEUTIC RESPONSE 83 0.0068
612 INCREASED APPETITE 130 0.0068
613 SENSORY DISTURBANCE 109 0.0068
614 CLOSTRIDIUM DIFFICILE COLITIS 72 0.0068
615 PAIN 4168 0.0068
616 VENTRICULAR TACHYCARDIA 112 0.0068
617 GAIT DISTURBANCE 1296 0.0068
618 URINE OUTPUT DECREASED 59 0.0067
619 DYSKINESIA 274 0.0067
620 FAECES DISCOLOURED 146 0.0067
621 COELIAC DISEASE 66 0.0067
622 ALANINE AMINOTRANSFERASE INCREASED 413 0.0067
623 INJECTION SITE URTICARIA 165 0.0067
624 HERNIA 130 0.0067
625 INFLUENZA LIKE ILLNESS 553 0.0067
626 DRUG ERUPTION 119 0.0067
627 AGGRESSION 336 0.0067
628 PLEURAL EFFUSION 408 0.0067
629 DIPLOPIA 174 0.0067
630 MUSCULAR WEAKNESS 760 0.0067
631 PRODUCT DISTRIBUTION ISSUE 62 0.0067
632 DIABETES MELLITUS 509 0.0067
633 ABDOMINAL PAIN 1553 0.0067
634 NEUTROPHIL COUNT DECREASED 272 0.0067
635 BASAL CELL CARCINOMA 104 0.0067
636 SPEECH DISORDER 349 0.0067
637 MEMORY IMPAIRMENT 914 0.0066
638 ACUTE MYOCARDIAL INFARCTION 196 0.0066
639 BLOOD THYROID STIMULATING HORMONE INCREASED 61 0.0066
640 HAEMOGLOBIN DECREASED 680 0.0066
641 SEPSIS 738 0.0066
642 THERAPEUTIC RESPONSE DECREASED 401 0.0066
643 COAGULOPATHY 110 0.0066
644 IMPAIRED DRIVING ABILITY 75 0.0066
645 NODULE 86 0.0066
646 AUTOIMMUNE DISORDER 64 0.0066
647 PERICARDIAL EFFUSION 151 0.0065
648 DRY SKIN 871 0.0065
649 HALLUCINATION 491 0.0065
650 CONDITION AGGRAVATED 1980 0.0065
651 COGNITIVE DISORDER 304 0.0065
652 HERPES ZOSTER 374 0.0065
653 SKIN EXFOLIATION 549 0.0065
654 EYE INFLAMMATION 62 0.0065
655 VOMITING 3054 0.0065
656 UPPER GASTROINTESTINAL HAEMORRHAGE 109 0.0065
657 TACHYCARDIA 575 0.0065
658 LEUKOCYTOSIS 117 0.0065
659 MENTAL DISORDER 281 0.0065
660 GASTROINTESTINAL PAIN 71 0.0064
661 SEDATION 169 0.0064
662 ANAEMIA 1225 0.0064
663 INCORRECT DOSE ADMINISTERED 1465 0.0064
664 ERUCTATION 124 0.0064
665 LOSS OF CONSCIOUSNESS 821 0.0064
666 LABORATORY TEST ABNORMAL 188 0.0064
667 INJECTION SITE RASH 195 0.0063
668 JOINT SWELLING 764 0.0063
669 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 304 0.0063
670 DIABETES MELLITUS INADEQUATE CONTROL 112 0.0063
671 DECREASED IMMUNE RESPONSIVENESS 62 0.0063
672 SURGERY 370 0.0063
673 DEVICE FAILURE 96 0.0063
674 CONFUSIONAL STATE 1019 0.0063
675 POST PROCEDURAL COMPLICATION 121 0.0063
676 ASPARTATE AMINOTRANSFERASE INCREASED 334 0.0063
677 ANGINA PECTORIS 180 0.0063
678 HEPATIC ENZYME INCREASED 428 0.0063
679 MULTIPLE FRACTURES 103 0.0063
680 COVID-19 PNEUMONIA 74 0.0063
681 INFLAMMATION 323 0.0063
682 IMPAIRED HEALING 205 0.0062
683 HEREDITARY ANGIOEDEMA 67 0.0062
684 LUNG INFECTION 97 0.0062
685 RESTLESSNESS 228 0.0062
686 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 209 0.0062
687 MUSCLE ATROPHY 78 0.0062
688 MALAISE 2697 0.0061
689 JOINT DISLOCATION 65 0.0061
690 DRUG PRESCRIBING ERROR 118 0.0061
691 LOWER LIMB FRACTURE 118 0.0061
692 MUSCULOSKELETAL STIFFNESS 538 0.0061
693 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1106 0.0061
694 PRESCRIBED OVERDOSE 118 0.0061
695 ROAD TRAFFIC ACCIDENT 254 0.0061
696 OVERDOSE 1305 0.0060
697 ARTHROPATHY 336 0.0060
698 GAIT INABILITY 202 0.0060
699 HYPOTENSION 1208 0.0060
700 LIVER FUNCTION TEST ABNORMAL 175 0.0060
701 MOVEMENT DISORDER 193 0.0060
702 GASTROINTESTINAL HAEMORRHAGE 502 0.0060
703 TOXIC EPIDERMAL NECROLYSIS 91 0.0060
704 ABDOMINAL PAIN LOWER 151 0.0060
705 INTENTIONAL DOSE OMISSION 170 0.0060
706 APHASIA 180 0.0060
707 RESPIRATORY FAILURE 434 0.0059
708 ALOPECIA 1168 0.0059
709 MACULAR DEGENERATION 71 0.0059
710 ELECTROLYTE IMBALANCE 69 0.0059
711 WOUND INFECTION 65 0.0059
712 RECTAL HAEMORRHAGE 255 0.0059
713 THROMBOSIS 477 0.0059
714 PRODUCT ODOUR ABNORMAL 62 0.0059
715 HEPATOMEGALY 58 0.0059
716 BACTERAEMIA 70 0.0059
717 GENERALISED OEDEMA 73 0.0059
718 SPINAL PAIN 69 0.0059
719 THERAPY CESSATION 302 0.0059
720 ADVERSE REACTION 78 0.0059
721 DISORIENTATION 233 0.0059
722 PRODUCT DOSE OMISSION ISSUE 1728 0.0059
723 HEART RATE DECREASED 206 0.0059
724 TOOTH EXTRACTION 73 0.0059
725 EJECTION FRACTION DECREASED 91 0.0058
726 THERAPEUTIC PRODUCT EFFECT DECREASED 261 0.0058
727 BLOOD CREATININE INCREASED 379 0.0058
728 DELUSION 90 0.0058
729 HEMIPARESIS 98 0.0058
730 BLOOD BILIRUBIN INCREASED 156 0.0058
731 VASCULITIS 67 0.0057
732 PNEUMOTHORAX 91 0.0057
733 UNRESPONSIVE TO STIMULI 148 0.0057
734 SEIZURE 659 0.0057
735 ABSCESS 91 0.0057
736 EMOTIONAL DISTRESS 689 0.0057
737 INJECTION SITE WARMTH 117 0.0057
738 HAEMATEMESIS 144 0.0057
739 PARALYSIS 81 0.0057
740 INTESTINAL OBSTRUCTION 213 0.0056
741 PRODUCT DOSE OMISSION 368 0.0056
742 MYDRIASIS 72 0.0056
743 INFECTION 812 0.0056
744 INJECTION SITE DISCOLOURATION 70 0.0056
745 HAEMATOMA 145 0.0056
746 LUNG DISORDER 274 0.0056
747 RASH MACULO-PAPULAR 124 0.0056
748 HYPERGLYCAEMIA 203 0.0056
749 GASTROINTESTINAL DISORDER 499 0.0056
750 CONVULSION 318 0.0056
751 ILEUS 69 0.0055
752 SKIN ULCER 143 0.0055
753 INJECTION SITE PRURITUS 370 0.0055
754 VISUAL IMPAIRMENT 684 0.0055
755 KNEE ARTHROPLASTY 116 0.0055
756 DRUG ADMINISTRATION ERROR 168 0.0055
757 MUSCULOSKELETAL DISORDER 104 0.0055
758 HALLUCINATION, VISUAL 115 0.0054
759 STEVENS-JOHNSON SYNDROME 121 0.0054
760 SPINAL FRACTURE 109 0.0054
761 PALLOR 148 0.0054
762 IMPAIRED WORK ABILITY 116 0.0054
763 PAIN OF SKIN 146 0.0054
764 INTENTIONAL PRODUCT USE ISSUE 475 0.0054
765 GINGIVAL BLEEDING 74 0.0054
766 CAESAREAN SECTION 63 0.0054
767 LIVER FUNCTION TEST INCREASED 116 0.0054
768 INTENTIONAL SELF-INJURY 109 0.0054
769 OFF LABEL USE 4717 0.0054
770 INTERNATIONAL NORMALISED RATIO INCREASED 153 0.0054
771 ORTHOSTATIC HYPOTENSION 93 0.0053
772 UNDERDOSE 389 0.0053
773 COLITIS 202 0.0053
774 HIP FRACTURE 171 0.0053
775 THERAPY NON-RESPONDER 239 0.0053
776 DISABILITY 105 0.0053
777 ATAXIA 63 0.0053
778 PSORIATIC ARTHROPATHY 215 0.0053
779 RESPIRATORY DISTRESS 146 0.0053
780 HIP ARTHROPLASTY 81 0.0053
781 HAEMATURIA 181 0.0053
782 SPINAL OPERATION 65 0.0053
783 DISEASE RECURRENCE 251 0.0053
784 INJECTION SITE NODULE 58 0.0053
785 PULMONARY OEDEMA 236 0.0053
786 BEDRIDDEN 69 0.0052
787 DEAFNESS 137 0.0052
788 PHARMACEUTICAL PRODUCT COMPLAINT 136 0.0052
789 LOWER RESPIRATORY TRACT INFECTION 238 0.0052
790 MANIA 86 0.0052
791 PRODUCT AVAILABILITY ISSUE 119 0.0052
792 MUSCLE SPASTICITY 64 0.0052
793 GLOMERULAR FILTRATION RATE DECREASED 64 0.0052
794 RENAL FAILURE ACUTE 221 0.0052
795 PROCEDURAL PAIN 144 0.0052
796 TENDON RUPTURE 64 0.0052
797 MOBILITY DECREASED 372 0.0052
798 ARRHYTHMIA 245 0.0052
799 HYPONATRAEMIA 290 0.0051
800 HAEMATOCHEZIA 283 0.0051
801 VAGINAL HAEMORRHAGE 222 0.0051
802 GAMMA-GLUTAMYLTRANSFERASE INCREASED 113 0.0051
803 BLOOD GLUCOSE DECREASED 244 0.0051
804 FEMUR FRACTURE 157 0.0051
805 INJECTION SITE SWELLING 385 0.0050
806 CYANOSIS 79 0.0050
807 DRUG INTERACTION 796 0.0050
808 PSORIASIS 655 0.0050
809 PRODUCT SUBSTITUTION ISSUE 288 0.0050
810 TACHYPNOEA 68 0.0050
811 FREQUENT BOWEL MOVEMENTS 135 0.0050
812 SUICIDE ATTEMPT 303 0.0050
813 METASTASES TO BONE 82 0.0050
814 INCORRECT PRODUCT ADMINISTRATION DURATION 108 0.0050
815 DEVICE OCCLUSION 70 0.0050
816 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1007 0.0050
817 MENTAL IMPAIRMENT 120 0.0049
818 TOOTH LOSS 102 0.0049
819 ANOREXIA 63 0.0049
820 HYPERCALCAEMIA 60 0.0049
821 SKIN BURNING SENSATION 348 0.0049
822 PLASMA CELL MYELOMA 189 0.0048
823 DYSMENORRHOEA 64 0.0048
824 INJECTION SITE BRUISING 385 0.0048
825 COMPLICATION ASSOCIATED WITH DEVICE 70 0.0048
826 SUBDURAL HAEMATOMA 69 0.0048
827 PANCREATITIS 254 0.0048
828 GLYCOSYLATED HAEMOGLOBIN INCREASED 121 0.0048
829 INJECTION SITE ERYTHEMA 593 0.0048
830 BRAIN OEDEMA 60 0.0047
831 PRODUCT PRESCRIBING ERROR 113 0.0047
832 ADVERSE DRUG REACTION 426 0.0047
833 WRONG TECHNIQUE IN DRUG USAGE PROCESS 172 0.0047
834 WOUND 132 0.0047
835 ACNE 354 0.0047
836 PRODUCT QUALITY ISSUE 634 0.0047
837 SKIN CANCER 100 0.0046
838 ASCITES 136 0.0046
839 INTRAOCULAR PRESSURE INCREASED 59 0.0046
840 HYPOACUSIS 198 0.0046
841 INTENTIONAL PRODUCT MISUSE 402 0.0046
842 DRUG DOSE OMISSION 758 0.0046
843 ELECTROCARDIOGRAM QT PROLONGED 164 0.0046
844 LIVER DISORDER 202 0.0046
845 TREATMENT NONCOMPLIANCE 249 0.0045
846 MUCOSAL INFLAMMATION 119 0.0045
847 BLINDNESS UNILATERAL 64 0.0045
848 HALLUCINATION, AUDITORY 72 0.0045
849 DRUG INTOLERANCE 437 0.0045
850 CARDIAC DISORDER 422 0.0045
851 THERAPY INTERRUPTED 320 0.0045
852 SKIN IRRITATION 205 0.0045
853 HAEMORRHAGE 467 0.0045
854 ENCEPHALOPATHY 109 0.0044
855 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 76 0.0044
856 VISUAL ACUITY REDUCED 147 0.0044
857 MULTIPLE SCLEROSIS 211 0.0044
858 MULTIPLE SCLEROSIS RELAPSE 300 0.0044
859 ABASIA 108 0.0044
860 RENAL IMPAIRMENT 366 0.0044
861 PRODUCT ADMINISTRATION ERROR 88 0.0043
862 SEPTIC SHOCK 189 0.0043
863 DEMENTIA 121 0.0043
864 MENORRHAGIA 85 0.0043
865 INTENTIONAL OVERDOSE 277 0.0043
866 WITHDRAWAL SYNDROME 181 0.0043
867 HYPERKALAEMIA 151 0.0043
868 CENTRAL NERVOUS SYSTEM LESION 59 0.0043
869 DISEASE PROGRESSION 508 0.0043
870 HYPOCALCAEMIA 81 0.0043
871 INCORRECT DRUG ADMINISTRATION DURATION 120 0.0043
872 INJECTION SITE REACTION 292 0.0042
873 INJECTION SITE PAIN 1284 0.0042
874 BRADYCARDIA 222 0.0042
875 CEREBROVASCULAR ACCIDENT 707 0.0042
876 THERAPY PARTIAL RESPONDER 65 0.0042
877 METRORRHAGIA 71 0.0042
878 HEPATIC CIRRHOSIS 78 0.0041
879 PANCREATITIS ACUTE 93 0.0041
880 RHEUMATOID ARTHRITIS 469 0.0041
881 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 96 0.0041
882 APATHY 60 0.0041
883 DRUG-INDUCED LIVER INJURY 129 0.0041
884 ANAPHYLACTIC SHOCK 105 0.0041
885 PSYCHOTIC DISORDER 120 0.0041
886 DELIRIUM 140 0.0040
887 PANCYTOPENIA 225 0.0040
888 EPILEPSY 123 0.0040
889 ERECTILE DYSFUNCTION 103 0.0040
890 EXPOSURE VIA SKIN CONTACT 103 0.0040
891 HOSPITALISATION 610 0.0040
892 HYPOGLYCAEMIA 192 0.0040
893 C-REACTIVE PROTEIN INCREASED 144 0.0040
894 BLOOD GLUCOSE ABNORMAL 73 0.0039
895 CARDIAC ARREST 326 0.0039
896 BLOOD LACTATE DEHYDROGENASE INCREASED 62 0.0039
897 JAUNDICE 105 0.0039
898 MYOCARDIAL INFARCTION 677 0.0039
899 PULMONARY FIBROSIS 74 0.0039
900 BLOOD GLUCOSE INCREASED 723 0.0038
901 HEPATITIS 98 0.0038
902 BLINDNESS 156 0.0038
903 CARDIO-RESPIRATORY ARREST 159 0.0038
904 OSTEONECROSIS OF JAW 94 0.0038
905 PREGNANCY 76 0.0038
906 DIABETIC KETOACIDOSIS 91 0.0038
907 METABOLIC ACIDOSIS 121 0.0038
908 ILL-DEFINED DISORDER 229 0.0038
909 EXPOSURE DURING PREGNANCY 234 0.0038
910 LYMPHOMA 58 0.0037
911 NEUTROPENIA 507 0.0037
912 BLOOD CREATINE PHOSPHOKINASE INCREASED 107 0.0037
913 INJECTION SITE MASS 137 0.0037
914 DEPRESSED LEVEL OF CONSCIOUSNESS 146 0.0037
915 MEDICATION ERROR 205 0.0037
916 THROMBOCYTOPENIA 410 0.0037
917 DEVICE DISLOCATION 159 0.0037
918 CEREBRAL INFARCTION 89 0.0036
919 NERVOUS SYSTEM DISORDER 113 0.0036
920 PRESCRIBED UNDERDOSE 72 0.0036
921 SYNOVITIS 65 0.0036
922 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 92 0.0036
923 DEVICE ISSUE 319 0.0036
924 MENSTRUATION IRREGULAR 95 0.0035
925 CHOLESTASIS 68 0.0035
926 CARDIAC FAILURE 284 0.0035
927 TARDIVE DYSKINESIA 99 0.0035
928 NO ADVERSE EVENT 631 0.0035
929 DYSTONIA 67 0.0035
930 SYSTEMIC LUPUS ERYTHEMATOSUS 122 0.0034
931 LEUKOPENIA 170 0.0034
932 APPLICATION SITE ERYTHEMA 89 0.0034
933 SHOCK 78 0.0034
934 CARDIOVASCULAR DISORDER 86 0.0034
935 MATERNAL EXPOSURE DURING PREGNANCY 301 0.0034
936 ABORTION SPONTANEOUS 135 0.0034
937 CONTRAINDICATED PRODUCT ADMINISTERED 102 0.0034
938 EOSINOPHILIA 59 0.0034
939 DEVICE MALFUNCTION 236 0.0034
940 PROTEINURIA 63 0.0033
941 METASTASES TO LIVER 58 0.0033
942 SEROTONIN SYNDROME 63 0.0033
943 FRACTURE 62 0.0033
944 APPLICATION SITE PAIN 72 0.0033
945 RESPIRATORY ARREST 90 0.0033
946 ADVERSE EVENT 292 0.0032
947 COLITIS ULCERATIVE 138 0.0031
948 INTERSTITIAL LUNG DISEASE 149 0.0031
949 GENERAL PHYSICAL HEALTH DETERIORATION 355 0.0031
950 INJECTION SITE HAEMORRHAGE 244 0.0031
951 MULTIPLE ORGAN DYSFUNCTION SYNDROME 86 0.0030
952 NEEDLE ISSUE 88 0.0030
953 TRANSAMINASES INCREASED 67 0.0030
954 MELAENA 65 0.0030
955 HEPATIC FUNCTION ABNORMAL 110 0.0029
956 DRUG EXPOSURE DURING PREGNANCY 100 0.0029
957 NEOPLASM PROGRESSION 102 0.0029
958 OSTEONECROSIS 96 0.0029
959 COMPLETED SUICIDE 237 0.0028
960 EXTRAPYRAMIDAL DISORDER 70 0.0028
961 ALTERED STATE OF CONSCIOUSNESS 61 0.0028
962 ACCIDENTAL EXPOSURE TO PRODUCT 290 0.0028
963 BREAST CANCER FEMALE 75 0.0028
964 MALIGNANT NEOPLASM PROGRESSION 285 0.0028
965 APPLICATION SITE PRURITUS 63 0.0028
966 DEVICE DELIVERY SYSTEM ISSUE 76 0.0028
967 PRODUCT DISPENSING ERROR 60 0.0028
968 LIVER INJURY 67 0.0027
969 HEPATIC FAILURE 81 0.0027
970 LUNG NEOPLASM MALIGNANT 110 0.0027
971 DEVICE BREAKAGE 106 0.0026
972 CEREBRAL HAEMORRHAGE 92 0.0026
973 NEOPLASM MALIGNANT 165 0.0025
974 LACTIC ACIDOSIS 75 0.0023
975 DEVICE LEAKAGE 100 0.0023
976 DEATH 1942 0.0023
977 TOXICITY TO VARIOUS AGENTS 372 0.0022
978 DRUG WITHDRAWAL SYNDROME 187 0.0021
979 RHABDOMYOLYSIS 88 0.0021
980 BREAST CANCER 196 0.0021
981 PRODUCT ADHESION ISSUE 75 0.0021
982 DEVICE USE ERROR 69 0.0020
983 TREATMENT FAILURE 162 0.0020
984 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 88 0.0019
985 INCORRECT ROUTE OF DRUG ADMINISTRATION 64 0.0018
986 FOETAL EXPOSURE DURING PREGNANCY 127 0.0016
987 DRUG DOSE OMISSION BY DEVICE 107 0.0014
988 PRODUCT STORAGE ERROR 114 0.0013
989 DEVICE EXPULSION 74 0.0011
990 DEVICE DIFFICULT TO USE 65 0.0010
991 DRUG DEPENDENCE 155 0.0010
992 PROSTATE CANCER 71 0.0009
993 DRUG ABUSE 65 0.0008